Conjunctivitis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials
• Forums

Subcutaneous Immunotherapy With BM41 in Patients With Allergic Rhino-conjunctivitis Caused by Birch Pollen
Conditions:   Birch Pollen Allergy;   Allergic Rhinoconjunctivitis Interventions:   Drug: BM41;   Other: Placebo;   Drug: ALK Alutard SQ Betula verrucosa Sponsors:   Odense University Hospital;   Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA);   Biomay AG;   European Commission;   University of Salzburg Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2021 Category: Research Source Type: clinical trials